亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Efficacy of Roflumilast Foam, 0.3%, in Patients With Seborrheic Dermatitis

医学 红斑 脂溢性皮炎 中止 头皮 临床试验 物理疗法 内科学 外科 皮肤病科
作者
Matthew Zirwas,Zoe Draelos,Janet DuBois,Leon Kircik,Angela Moore,Linda Stein Gold,Javier Alonso‐Llamazares,Michael Bukhalo,Suzanne Bruce,Kimmie Eads,Lawrence J. Green,Scott Guenthner,Laura K. Ferris,Seth Forman,Steven Kempers,Edward Lain,Charles Lynde,David M. Pariser,Darryl Toth,Paul S. Yamauchi,Robert Higham,David Krupa,Patrick Burnett,David R. Berk
出处
期刊:JAMA Dermatology [American Medical Association]
卷期号:159 (6): 613-613 被引量:13
标识
DOI:10.1001/jamadermatol.2023.0846
摘要

Importance Current topical treatment options for seborrheic dermatitis are limited by efficacy and/or safety. Objective To assess safety and efficacy of roflumilast foam, 0.3%, in adult patients with seborrheic dermatitis affecting the scalp, face, and/or trunk. Design, Setting, and Participants This multicenter (24 sites in the US and Canada) phase 2a, parallel group, double-blind, vehicle-controlled clinical trial was conducted between November 12, 2019, and August 21, 2020. Participants were adult (aged ≥18 years) patients with a clinical diagnosis of seborrheic dermatitis for a 3-month or longer duration and Investigator Global Assessment (IGA) score of 3 or greater (at least moderate), affecting 20% or less body surface area, including scalp, face, trunk, and/or intertriginous areas. Data analysis was performed from September to October 2020. Interventions Once-daily roflumilast foam, 0.3% (n = 154), or vehicle foam (n = 72) for 8 weeks. Main Outcomes and Measures The main outcome was IGA success, defined as achievement of IGA score of clear or almost clear plus 2-grade improvement from baseline, at week 8. Secondary outcomes included IGA success at weeks 2 and 4; achievement of erythema score of 0 or 1 plus 2-grade improvement from baseline at weeks 2, 4, and 8; achievement of scaling score of 0 or 1 plus 2-grade improvement from baseline at weeks 2, 4, and 8; change in Worst Itch Numeric Rating Scale (WI-NRS) score from baseline; and WI-NRS success, defined as achievement of 4-point or greater WI-NRS score improvement in patients with baseline WI-NRS score of 4 or greater. Safety and tolerability were also assessed. Results A total of 226 patients (mean [SD] age, 44.9 [16.8] years; 116 men, 110 women) were randomized to roflumilast foam (n = 154) or vehicle foam (n = 72). At week 8, 104 (73.8%) roflumilast-treated patients achieved IGA success compared with 27 (40.9%) in the vehicle group ( P < .001). Roflumilast-treated patients had statistically significantly higher rates of IGA success vs vehicle at week 2, the first time point assessed. Mean (SD) reductions (improvements) on the WI-NRS at week 8 were 59.3% (52.5%) vs 36.6% (42.2%) in the roflumilast and vehicle groups, respectively ( P < .001). Roflumilast was well tolerated, with the rate of adverse events similar to that of the vehicle foam. Conclusions and Relevance The results from this phase 2a randomized clinical trial of once-daily roflumilast foam, 0.3%, demonstrated favorable efficacy, safety, and local tolerability in the treatment of erythema, scaling, and itch caused by seborrheic dermatitis, supporting further investigation as a nonsteroidal topical treatment. Trial Registration ClinicalTrials.gov Identifier: NCT04091646
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zsmj23完成签到 ,获得积分0
58秒前
阳和启蛰完成签到 ,获得积分10
1分钟前
1分钟前
CATH完成签到 ,获得积分10
1分钟前
翟半仙发布了新的文献求助20
1分钟前
翟半仙完成签到,获得积分20
1分钟前
hzc应助科研通管家采纳,获得10
1分钟前
小二郎应助科研通管家采纳,获得10
1分钟前
英姑应助科研通管家采纳,获得10
1分钟前
hzc应助科研通管家采纳,获得10
1分钟前
2分钟前
pyzhu完成签到,获得积分10
2分钟前
zly完成签到 ,获得积分10
2分钟前
斯文果汁完成签到,获得积分10
3分钟前
3分钟前
guan完成签到,获得积分10
4分钟前
guan发布了新的文献求助10
4分钟前
努力的小胡完成签到 ,获得积分10
4分钟前
努力的小胡关注了科研通微信公众号
4分钟前
Tim完成签到 ,获得积分10
5分钟前
33完成签到,获得积分10
5分钟前
caca完成签到,获得积分10
5分钟前
6分钟前
禹奎发布了新的文献求助10
6分钟前
pass完成签到 ,获得积分10
6分钟前
6分钟前
乐生发布了新的文献求助10
6分钟前
禹奎发布了新的文献求助10
6分钟前
大个应助乐生采纳,获得10
6分钟前
禹奎完成签到,获得积分10
6分钟前
pluto应助guan采纳,获得10
6分钟前
盒子应助guan采纳,获得10
6分钟前
Una完成签到,获得积分10
6分钟前
熊星星完成签到 ,获得积分10
6分钟前
谢小盟完成签到 ,获得积分10
7分钟前
zhanglh完成签到 ,获得积分10
8分钟前
8分钟前
zhanglh发布了新的文献求助10
8分钟前
CHENCHEN完成签到,获得积分10
9分钟前
爆米花应助希勤采纳,获得10
9分钟前
高分求助中
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Bayesian Models of Cognition:Reverse Engineering the Mind 888
Le dégorgement réflexe des Acridiens 800
Defense against predation 800
XAFS for Everyone (2nd Edition) 600
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3133930
求助须知:如何正确求助?哪些是违规求助? 2784836
关于积分的说明 7768641
捐赠科研通 2440188
什么是DOI,文献DOI怎么找? 1297291
科研通“疑难数据库(出版商)”最低求助积分说明 624911
版权声明 600791